Senate Confirms McClellan As FDA Commissioner, Ending 21-Month Wait
This article was originally published in The Gray Sheet
Executive Summary
The Senate ended FDA's longest interim period without a commissioner (21 months) by confirming Mark McClellan, MD/PhD, to the post Oct. 17